First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial.
about
Localized malignant pleural sarcomatoid mesothelioma misdiagnosed as benign localized fibrous tumorA phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.Update on current and potential nanoparticle cancer therapiesTumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma.Pegylated liposomal doxorubicin in malignant pleural mesothelioma: a possible guardian for long-term survival.Histone Deacetylase Inhibitors Delivery using Nanoparticles with Intrinsic Passive Tumor Targeting Properties for Tumor TherapyMalignant pleural mesothelioma: current and future perspectivesRethinking cancer nanotheranostics.Superresolution imaging of individual replication forks reveals unexpected prodrug resistance mechanism.Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy.Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.The use of patient-reported outcome measures (PROMs) in the management of malignant pleural mesothelioma: a descriptive literature survey
P2860
Q28395488-0756547B-5E6B-40F2-9976-1530409C3456Q33414357-2A1C6535-4F4F-41E0-8548-97E544A09F52Q33874239-C4A1591C-A716-4A0E-AFDC-B1CC02932322Q35880415-214C793C-FC87-4A7B-8E2A-04B77BFAE871Q36295049-7FB5AB2B-D36D-4D5D-837B-B8914C493CDCQ36882942-C4A54F5B-84B7-4BC9-8522-0415654923D5Q37217764-E33A90DB-1573-4C11-87DE-C6D53BBF70C0Q42640884-A4852FA4-0E42-457C-B870-3ED99AD2B1FAQ49596672-B18F548B-3421-4F18-867D-757A9A6A81B3Q52815685-6BE32CD5-EC9D-4216-832A-BACAC381D9B3Q53067337-A33EFA8D-2B8B-4D37-86D0-754B80BCADDEQ59132459-0039D926-38E3-4F60-AD33-6A04880C3415
P2860
First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
First-line chemotherapy with l ...... mesothelioma: phase II trial.
@ast
First-line chemotherapy with l ...... mesothelioma: phase II trial.
@en
type
label
First-line chemotherapy with l ...... mesothelioma: phase II trial.
@ast
First-line chemotherapy with l ...... mesothelioma: phase II trial.
@en
prefLabel
First-line chemotherapy with l ...... mesothelioma: phase II trial.
@ast
First-line chemotherapy with l ...... mesothelioma: phase II trial.
@en
P2093
P2860
P356
P1476
First-line chemotherapy with l ...... l mesothelioma: phase II trial
@en
P2093
D Motola-Kuba
E Estrada-Lobato
E O Macedo
G Villanueva-Rodríguez
J F Corona-Cruz
L Martínez-Barrera
N Hernández-Pedro
V López-Rodríguez
P2860
P2888
P304
P356
10.1038/BJC.2012.44
P407
P577
2012-02-21T00:00:00Z